Barker, Lucy C.
Dennis, Cindy-Lee
Hussain-Shamsy, Neesha
Stewart, Donna E.
Grigoriadis, Sophie
Metcalfe, Kelly
Oberlander, Tim F.
Schram, Carrie
Taylor, Valerie H.
Vigod, Simone N.
Funding for this research was provided by:
Canadian Institutes of Health Research (FRN-133662)
Article History
Received: 11 August 2019
Accepted: 31 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The parent trial was approved by the Research Ethics Board (REB) at Women’s College Hospital, and written informed consent was obtained from all individual participants included in the study as per the REB-approved protocol.
: Not applicable.
: D.E.S. reports personal fees from the Scientific Advisory Committee, Duloxetine Pregnancy Registry, Eli Lilly, outside the submitted work. V.H.T. reports consulting work for Sunovion, Shire, NovoNordisk, and Valeant. S.G. reports personal fees from UpToDate, personal fees from Eli Lilly, personal fees from Compendium of Pharmaceuticals, other fees from Allergan, personal fees from Pfizer, other fees from Sage, and personal fees from Psychotherapy to go, outside the submitted work.